- call +1-201-465-4211
- email sales@mrinsights.biz
Capsule-based inhalers belong to the category of dry powder inhalers and work according to a simple two-step procedure. Capsules are punctured or opened by pressing the device buttons. Then, after inspiration, powder is absorbed into the lung pathway.
Scope of the Report:
The worldwide market for Capsule-based Inhalers is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.
This report focuses on the Capsule-based Inhalers in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Hovione
Iconovo AB
Inbrija
Utibron Neohaler (Novartis AG)
Zibo Laixu Medical Equipment Co
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Gelatin Capsules
Hypromellose Capsules
Market Segment by Applications, can be divided into
Asthma
COPD (Chronic Obstructive Pulmonary Disease)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Capsule-based Inhalers product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Capsule-based Inhalers, with price, sales, revenue and global market share of Capsule-based Inhalers in 2017 and 2018.
Chapter 3, the Capsule-based Inhalers competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Capsule-based Inhalers breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Capsule-based Inhalers market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Capsule-based Inhalers sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Capsule-based Inhalers Introduction
1.2 Market Analysis by Type
1.2.1 Gelatin Capsules
1.2.2 Hypromellose Capsules
1.3 Market Analysis by Applications
1.3.1 Asthma
1.3.2 COPD (Chronic Obstructive Pulmonary Disease)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hovione
2.1.1 Business Overview
2.1.2 Capsule-based Inhalers Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hovione Capsule-based Inhalers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Iconovo AB
2.2.1 Business Overview
2.2.2 Capsule-based Inhalers Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Iconovo AB Capsule-based Inhalers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Inbrija
2.3.1 Business Overview
2.3.2 Capsule-based Inhalers Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Inbrija Capsule-based Inhalers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Utibron Neohaler (Novartis AG)
2.4.1 Business Overview
2.4.2 Capsule-based Inhalers Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Utibron Neohaler (Novartis AG) Capsule-based Inhalers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Zibo Laixu Medical Equipment Co
2.5.1 Business Overview
2.5.2 Capsule-based Inhalers Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Zibo Laixu Medical Equipment Co Capsule-based Inhalers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Capsule-based Inhalers Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Capsule-based Inhalers Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Capsule-based Inhalers Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Capsule-based Inhalers Manufacturer Market Share in 2018
3.3.2 Top 6 Capsule-based Inhalers Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Capsule-based Inhalers Market Analysis by Regions
4.1 Global Capsule-based Inhalers Sales, Revenue and Market Share by Regions
4.1.1 Global Capsule-based Inhalers Sales and Market Share by Regions (2014-2019)
4.1.2 Global Capsule-based Inhalers Revenue and Market Share by Regions (2014-2019)
4.2 North America Capsule-based Inhalers Sales and Growth Rate (2014-2019)
4.3 Europe Capsule-based Inhalers Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Capsule-based Inhalers Sales and Growth Rate (2014-2019)
4.5 South America Capsule-based Inhalers Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Capsule-based Inhalers Sales and Growth Rate (2014-2019)
5 North America Capsule-based Inhalers by Country
5.1 North America Capsule-based Inhalers Sales, Revenue and Market Share by Country
5.1.1 North America Capsule-based Inhalers Sales and Market Share by Country (2014-2019)
5.1.2 North America Capsule-based Inhalers Revenue and Market Share by Country (2014-2019)
5.2 United States Capsule-based Inhalers Sales and Growth Rate (2014-2019)
5.3 Canada Capsule-based Inhalers Sales and Growth Rate (2014-2019)
5.4 Mexico Capsule-based Inhalers Sales and Growth Rate (2014-2019)
6 Europe Capsule-based Inhalers by Country
6.1 Europe Capsule-based Inhalers Sales, Revenue and Market Share by Country
6.1.1 Europe Capsule-based Inhalers Sales and Market Share by Country (2014-2019)
6.1.2 Europe Capsule-based Inhalers Revenue and Market Share by Country (2014-2019)
6.2 Germany Capsule-based Inhalers Sales and Growth Rate (2014-2019)
6.3 UK Capsule-based Inhalers Sales and Growth Rate (2014-2019)
6.4 France Capsule-based Inhalers Sales and Growth Rate (2014-2019)
6.5 Russia Capsule-based Inhalers Sales and Growth Rate (2014-2019)
6.6 Italy Capsule-based Inhalers Sales and Growth Rate (2014-2019)
7 Asia-Pacific Capsule-based Inhalers by Country
7.1 Asia-Pacific Capsule-based Inhalers Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Capsule-based Inhalers Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Capsule-based Inhalers Revenue and Market Share by Country (2014-2019)
7.2 China Capsule-based Inhalers Sales and Growth Rate (2014-2019)
7.3 Japan Capsule-based Inhalers Sales and Growth Rate (2014-2019)
7.4 Korea Capsule-based Inhalers Sales and Growth Rate (2014-2019)
7.5 India Capsule-based Inhalers Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Capsule-based Inhalers Sales and Growth Rate (2014-2019)
8 South America Capsule-based Inhalers by Country
8.1 South America Capsule-based Inhalers Sales, Revenue and Market Share by Country
8.1.1 South America Capsule-based Inhalers Sales and Market Share by Country (2014-2019)
8.1.2 South America Capsule-based Inhalers Revenue and Market Share by Country (2014-2019)
8.2 Brazil Capsule-based Inhalers Sales and Growth Rate (2014-2019)
8.3 Argentina Capsule-based Inhalers Sales and Growth Rate (2014-2019)
8.4 Colombia Capsule-based Inhalers Sales and Growth Rate (2014-2019)
9 Middle East and Africa Capsule-based Inhalers by Countries
9.1 Middle East and Africa Capsule-based Inhalers Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Capsule-based Inhalers Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Capsule-based Inhalers Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Capsule-based Inhalers Sales and Growth Rate (2014-2019)
9.3 Turkey Capsule-based Inhalers Sales and Growth Rate (2014-2019)
9.4 Egypt Capsule-based Inhalers Sales and Growth Rate (2014-2019)
9.5 Nigeria Capsule-based Inhalers Sales and Growth Rate (2014-2019)
9.6 South Africa Capsule-based Inhalers Sales and Growth Rate (2014-2019)
10 Global Capsule-based Inhalers Market Segment by Type
10.1 Global Capsule-based Inhalers Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Capsule-based Inhalers Sales and Market Share by Type (2014-2019)
10.1.2 Global Capsule-based Inhalers Revenue and Market Share by Type (2014-2019)
10.2 Gelatin Capsules Sales Growth and Price
10.2.1 Global Gelatin Capsules Sales Growth (2014-2019)
10.2.2 Global Gelatin Capsules Price (2014-2019)
10.3 Hypromellose Capsules Sales Growth and Price
10.3.1 Global Hypromellose Capsules Sales Growth (2014-2019)
10.3.2 Global Hypromellose Capsules Price (2014-2019)
11 Global Capsule-based Inhalers Market Segment by Application
11.1 Global Capsule-based Inhalers Sales Market Share by Application (2014-2019)
11.2 Asthma Sales Growth (2014-2019)
11.3 COPD (Chronic Obstructive Pulmonary Disease) Sales Growth (2014-2019)
12 Capsule-based Inhalers Market Forecast (2019-2024)
12.1 Global Capsule-based Inhalers Sales, Revenue and Growth Rate (2019-2024)
12.2 Capsule-based Inhalers Market Forecast by Regions (2019-2024)
12.2.1 North America Capsule-based Inhalers Market Forecast (2019-2024)
12.2.2 Europe Capsule-based Inhalers Market Forecast (2019-2024)
12.2.3 Asia-Pacific Capsule-based Inhalers Market Forecast (2019-2024)
12.2.4 South America Capsule-based Inhalers Market Forecast (2019-2024)
12.2.5 Middle East and Africa Capsule-based Inhalers Market Forecast (2019-2024)
12.3 Capsule-based Inhalers Market Forecast by Type (2019-2024)
12.3.1 Global Capsule-based Inhalers Sales Forecast by Type (2019-2024)
12.3.2 Global Capsule-based Inhalers Market Share Forecast by Type (2019-2024)
12.4 Capsule-based Inhalers Market Forecast by Application (2019-2024)
12.4.1 Global Capsule-based Inhalers Sales Forecast by Application (2019-2024)
12.4.2 Global Capsule-based Inhalers Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Capsule-based Inhalers Picture
Table Product Specifications of Capsule-based Inhalers
Figure Global Sales Market Share of Capsule-based Inhalers by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
